Case studies to help you overcome formulation challenges
Patient adherence to prescribed therapy is widely recognized as a significant issue. Several factors, such as poor taste, administration difficulty, dosing frequency, and inconvenience, are attributed to the lack of patient acceptance and adherence to a prescribed regimen. Additionally, patient non-adherence can result in billions of lost revenue annually for the pharmaceutical industry due to prescriptions not filled or not re-filled by patients.
In this complimentary webinar, you will gain valuable insights in to how patient-centric drug formulations can help you overcome oral drug delivery challenges.
This webinar includes 4 case studies featuring unique solutions for patients with diverse needs:
- Providing the most convenient dosage formulation for better patient adherence
- Taste masking drugs with an unpleasant or bitter taste
- Orally disintegrating tablet technology for pediatric and elderly patients, and those who have difficulty swallowing
- Demonstrating bioequivalence and achieving regulatory approval with new formulations
- Improving the safety profile of drugs and reducing health care costs
You will also have an opportunity to take part in an exclusive Q&A session with Anthony Recupero, PhD, and Stefania Pagani, PhD., from Aptalis Pharmaceutical Technologies. Let our experts answer your questions and see how Aptalis Pharmaceutical Technologies can help transform your oral delivery challenges into proprietary product solutions.
Register now and transform the value of your portfolio.
Presented by
Anthony Recupero, PhD,
Senior Director Licensing, Aptalis Pharmaceutical Technologies
Anthony Recupero, PhD, is currently Senior Director, Licensing at Aptalis Pharmaceutical Technologies where he is responsible for global new business development and licensing. Prior to this role, Dr. Recupero was VP, Business Development at MaxCyte Inc., a cell therapeutics company, where he led all business development and licensing activities. Dr. Recupero previously served as Senior Director, Business Development at Gene Logic and has held several other business development and marketing positions in the biotech, bioinformatics, and biochemical industries. He earned his PhD in Cell & Molecular Biology from the University of Cincinnati and did his postdoctoral research in molecular oncology at the Cleveland Clinic.
Stefania Pagani, PhD.,
Associate Formulation Scientist, R&D
Stefania Pagani is an Associate Formulation Scientist at Aptalis Pharmaceutical Technologies where she is involved in developing new drug products, modified release dosage forms, taste masking technologies and bioavailability enhancement. Dr Pagani has several years of experience in pharmaceutical technologies and problem solving in scale up activities.
